UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051503
Receipt number R000058756
Scientific Title Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.
Date of disclosure of the study information 2023/07/03
Last modified on 2023/07/02 23:32:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.

Acronym

Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.

Scientific Title

Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.

Scientific Title:Acronym

Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.

Region

Japan


Condition

Condition

non-small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To investigate appropriate testing in cases of necrosis-rich non-small cell lung cancer by performing and comparing various multi-gene tests on blood, FFPE and cytology specimens.

Basic objectives2

Others

Basic objectives -Others

Utility of various multigene tests for necrosis-rich non-small cell lung cancer.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Success rate of analysis using ODxTT and AmoyDx with FFPE specimens and Compact Panel Dx with FFPE or cytology specimens.

Key secondary outcomes

Comparison of success rates between ODxTT and Compact Panel Dx; comparison of success rates between ODxTT and AmoyDx; driver gene detection rates by analysis using ODxTT and AmoyDx in FFPE specimens and Compact Panel Dx using FFPE or cytology specimens.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(i) Patients whose FFPE led to a diagnosis of non-small cell lung cancer
(ii) Necrotic component >20% after macrodissection
(iii) Blood tests can be collected before treatment
(iv) Age at the time of obtaining consent must be 20 years or older
(v) Written consent to participate in this study has been obtained from the patient.

Key exclusion criteria

(i) Cases where it is deemed difficult to submit ODxTT and AmoyDx with FFPE specimens, and Compact Panel Dx with FFPE or cytology specimens due to sample volume, or where the aforementioned multi-gene tests make it difficult to submit other tests considered necessary in routine clinical practice.
(ii) Cases in which the tumor cell percentage is less than 30% even if macrodissection is performed.
(iii) Other cases deemed unsuitable by the physician in charge.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name Sakaguchi

Organization

Matsusaka Municipal Hospital

Division name

Department of Respiratory Medicine

Zip code

515-0073

Address

1550, Tonomachi, Matsusaka, Mie

TEL

+81598231515

Email

iwbd0524@yahoo.co.jp


Public contact

Name of contact person

1st name Tadashi
Middle name
Last name Sakaguchi

Organization

Matsusaka Municipal Hospital

Division name

Department of Respiratory Medicine

Zip code

515-0073

Address

1550, Tonomachi, Matsusaka, Mie

TEL

+81598231515

Homepage URL


Email

mchsakaguchi@city-hosp.matsusaka.mie.jp


Sponsor or person

Institute

Matsusaka Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

Matsusaka Municipal Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board of Matsusaka Municipal Hospital

Address

1550, Tonomachi, Matsusaka, Mie.

Tel

0598-23-1515

Email

mch1031@city-hosp.matsusaka.mie.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 06 Month 09 Day

Date of IRB

2023 Year 06 Month 23 Day

Anticipated trial start date

2023 Year 07 Month 03 Day

Last follow-up date

2025 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The study is ongoing.


Management information

Registered date

2023 Year 07 Month 02 Day

Last modified on

2023 Year 07 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058756


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name